Beijing Aosaikang Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Beijing Aosaikang Pharmaceutical has a total shareholder equity of CN¥3.0B and total debt of CN¥84.0M, which brings its debt-to-equity ratio to 2.8%. Its total assets and total liabilities are CN¥3.7B and CN¥650.8M respectively.
Key information
2.8%
Debt to equity ratio
CN¥84.03m
Debt
Interest coverage ratio | n/a |
Cash | CN¥1.89b |
Equity | CN¥3.04b |
Total liabilities | CN¥650.80m |
Total assets | CN¥3.69b |
Recent financial health updates
Recent updates
Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) 26% Price Boost Is Out Of Tune With Revenues
May 21Is Beijing Aosaikang Pharmaceutical (SZSE:002755) Using Debt In A Risky Way?
Apr 29There's Reason For Concern Over Beijing Aosaikang Pharmaceutical Co., Ltd.'s (SZSE:002755) Massive 27% Price Jump
Mar 13Financial Position Analysis
Short Term Liabilities: 002755's short term assets (CN¥2.3B) exceed its short term liabilities (CN¥571.0M).
Long Term Liabilities: 002755's short term assets (CN¥2.3B) exceed its long term liabilities (CN¥79.8M).
Debt to Equity History and Analysis
Debt Level: 002755 has more cash than its total debt.
Reducing Debt: 002755's debt to equity ratio has increased from 0.2% to 2.8% over the past 5 years.
Debt Coverage: 002755's debt is well covered by operating cash flow (336.3%).
Interest Coverage: Insufficient data to determine if 002755's interest payments on its debt are well covered by EBIT.